Additionally, various epigenetic changes are known to be present in AD [60], and alterations in the epigenetic landscape at TOP2B target sites may potentially change TOP2B recognition as well as its enzymatic activity in generating DSBs. The gene discussed is TOP2B; the disease is Alzheimer disease.